Saturday, 31 October 2026European Markets

IRISH CONT. GP. And ARCADIS Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(VIANEWS) - IRISH CONT. GP. (IR5B.IR) is among this list of stock assets with the highest dividend rate and return on equity on the Industrials sector.

Financial Asset Price Forward Dividend Yield Return on Equity
IRISH CONT. GP. (IR5B.IR) €5.50 2.73% 22.98%
ARCADIS (ARCAD.AS) €64.45 1.33% 18.49%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. IRISH CONT. GP. (IR5B.IR)

2.73% Forward Dividend Yield and 22.98% Return On Equity

Irish Continental Group plc operates as a maritime transport company. It operates through two segments, Ferries, and Container and Terminal. The Ferries segment provides ferry services carrying passengers and roll on roll off freight on short sea routes on routes between Ireland, Britain, and Continental Europe under the Irish ferries brand; and chartering services. The Container and Terminal segment provides door-to-door and feeder lift on lift off freight services under the Eucon brand, stevedoring, and other related terminal services, as well as operates container terminals in the ports of Dublin and Belfast. The company provides container shipping, ship leasing, administration, and container handling services. In addition, it operates ferry; and act as a shipping and forwarding agency; as well as is involved in non-trading activities. Irish Continental Group plc was founded in 1972 and is based in Dublin, Ireland.

Earnings Per Share

As for profitability, IRISH CONT. GP. has a trailing twelve months EPS of €0.36.

PE Ratio

IRISH CONT. GP. has a trailing twelve months price to earnings ratio of 15.28. Meaning, the purchaser of the share is investing €15.28 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.98%.

Yearly Top and Bottom Value

IRISH CONT. GP.'s stock is valued at €5.50 at 12:30 EST, below its 52-week high of €6.00 and way higher than its 52-week low of €4.19.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Sep 12, 2024, the estimated forward annual dividend rate is 0.15 and the estimated forward annual dividend yield is 2.73%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 593.5M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, IRISH CONT. GP.'s stock is considered to be overbought (>=80).

More news about IRISH CONT. GP..

2. ARCADIS (ARCAD.AS)

1.33% Forward Dividend Yield and 18.49% Return On Equity

Arcadis NV offers design, engineering, and consultancy solutions for natural and built assets in The Americas, Europe, the Middle East, and the Asia Pacific. It operates through Places, Mobility, Resilience, and Intelligence segments. The company offers architectural and urbanism services; and asset management services, such as asset management strategy and planning, asset management decision making and operational optimization, life cycle planning and asset management systems, asset information/condition assessment, risk and review, organization and people, and asset management/O&M. It also provides business advisory services, including asset strategy and performance, business transformation and resiliency, investment and finance, operations and maintenance, and technology and information; contract solutions; cost and commercial management services; and design and engineering solutions for highways, railways, bridges, tunnels, power utilities, water utilities, ports and waterways, geotechnics, architecture, and structures, as well as building mechanical, electrical, and plumbing. In addition, the company offers digital environmental health safety and sustainability, environmental restoration, and project management solutions. Further, it provides mobility solutions for connected highways, intelligent rail and transit, integrated airports, and new mobility; places solutions; resilience solutions, such as energy transition, climate adaption, water optimization, enviro socio permitting, sustainable advisory, environmental restoration, and sustainable operations; and water supply and treatment, distribution, resource management, and industrial water and wastewater services. The company was formerly known as Heidemij NV and changed its name to Arcadis N.V. in October 1997. Arcadis NV was founded in 1888 and is headquartered in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, ARCADIS has a trailing twelve months EPS of €2.25.

PE Ratio

ARCADIS has a trailing twelve months price to earnings ratio of 28.64. Meaning, the purchaser of the share is investing €28.64 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.49%.

Volume

Today's last reported volume for ARCADIS is 65186 which is 72.65% below its average volume of 238379.

Moving Average

ARCADIS's worth is higher than its 50-day moving average of €62.95 and way higher than its 200-day moving average of €56.69.

Volatility

ARCADIS's last week, last month's, and last quarter's current intraday variation average was a negative 0.03%, a positive 0.20%, and a positive 0.96%.

ARCADIS's highest amplitude of average volatility was 0.81% (last week), 0.68% (last month), and 0.96% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 1.4%, now sitting on 5.04B for the twelve trailing months.

More news about ARCADIS.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com